Lack of FDA resources extends clinical hold on ALS drug NUZ-001
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.| ALS News Today
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.| ALS News Today
Category archive page for Columns.| ALS News Today
ALS is a neurodegenerative disorder marked by progressively worsening muscle weakness and neurological dysfunction.| ALS News Today
ALS is a progressive neurological disorder that damages motor neurons. Learn more about types, causes, symptoms, diagnosis, and treatment.| ALS News Today
